Evidence map›Paper›PMID 40247885›Full record

ArticleJournal of neuroendovascular therapy2025

Re-Stenting Following Recurrence after Successful Venous Sinus Stenosis Stenting for Idiopathic Intracranial Hypertension.

Salvatore A D'Amato, Juan Carlos Martinez Gutierrez, Hussein A Zeineddine, Eric Claude Mohan, Tien Nguyen, Cybele Woon, Rosa Tang, Peng Roc Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuroendovascular therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Salvatore A D'AmatoDepartment of Neurosurgery, University of Texas Health Science Center at Houston, John P. and Katherine G. McGovern Medical School, Houston, TX, USA.
Juan Carlos Martinez GutierrezDepartment of Neurosurgery, University of Texas Health Science Center at Houston, John P. and Katherine G. McGovern Medical School, Houston, TX, USA.
Hussein A ZeineddineDepartment of Neurosurgery, University of Texas Health Science Center at Houston, John P. and Katherine G. McGovern Medical School, Houston, TX, USA.
Eric Claude MohanJohn P. and Katherine G. McGovern Medical School, Houston, TX, USA.
Tien NguyenDepartment of Neurosurgery, University of Texas Health Science Center at Houston, John P. and Katherine G. McGovern Medical School, Houston, TX, USA.
Cybele WoonWhitsett Vision Group, Houston, TX, USA.
Rosa TangEye Wellness Center, Houston, TX, USA.
Peng Roc ChenDepartment of Neurosurgery, University of Texas Health Science Center at Houston, John P. and Katherine G. McGovern Medical School, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: In medically refractory idiopathic intracranial hypertension (IIH), venous sinus stenosis (VSS) stenting has been an effective treatment modality. Among patients who experience recurrent symptoms and develop new stenosis, the optimal treatment strategy is unknown. The aim of this study was to investigate the role of rescue re-stenting in patients with recurrence after prior successful stenting. Methods: This was a single center, retrospective review from a prospectively maintained IIH registry. Between 2012 and 2023, patients who underwent interventions for confirmed IIH and angiographically demonstrable VSS were included. The cohort was divided into those who underwent a single stenting procedure (single stent group) and those who underwent re-stenting due to recurrence of symptoms and new angiographic stenosis (re-stent group). Results: Ninety seven patients were included: 87 in the single stent group and 10 in the re-stent group, with a median age of 32 (interquartile range 26-38). 94% were female. Both groups had similar baseline demographic and clinical characteristics. There was similar improvement in papilledema and tinnitus. Headache improvement was greater in the single stent group at 6 weeks (88.4% vs. 60.0%, p = 0.04, single vs. re-stent group), but similar at 6 months post-procedure. For visual disturbances, there was similar improvement at 6 weeks, but greater improvement in the single stent group at 6 months post-procedure (86.8% vs. 75.0%, p = 0.04, single vs. re-stent group). None of the re-stented patients required rescue ventriculoperitoneal shunt placement. Conclusion: Re-stenting among IIH patients with recurrent symptoms after initial successful VSS stenting is feasible with similar efficacy in improving symptoms.

Indexed as

idiopathic intracranial hypertensionvenous sinus stenosisvenous sinus stenting

Identifiers

PMID40247885
PMCPMC12004401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.